Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | PDE4A | P27815 | 1/20 | 0.47 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.47 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.47 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.47 |
| ▸ | SLC29A1 | Q99808 | 16/20 | 0.44 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.43 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.43 |
| ▸ | STAT6 | P42226 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13844404 | 0.83 | PRMT5 (0.61) | SMN1; SMN2SLC29A1PRMT5WDR77STAT6 | |
| SCHEMBL31228232 | 0.81 | SLC29A1 (0.44) | SLC29A1PRMT5WDR77 | |
| SCHEMBL25390968 | 0.76 | ADORA3 (0.57) | SMN1; SMN2SLC29A1PRMT5WDR77STAT6 | |
| SCHEMBL25388043 | 0.76 | ADORA3 (0.57) | SMN1; SMN2SLC29A1PRMT5WDR77STAT6 | |
| SCHEMBL26239618 | 0.76 | ADORA3 (0.57) | SMN1; SMN2SLC29A1PRMT5WDR77STAT6 | |
| SCHEMBL240981 | 0.76 | SMN1; SMN2 (0.77) | TP53SMN1; SMN2SLC29A1STAT6 | |
| SCHEMBL672036 | 0.76 | SMN1; SMN2 (0.77) | TP53SMN1; SMN2SLC29A1STAT6 | |
| SCHEMBL7134319 | 0.76 | SMN1; SMN2 (0.77) | TP53SMN1; SMN2SLC29A1STAT6 | |
| SCHEMBL30089484 | 0.76 | SMN1; SMN2 (0.77) | TP53SMN1; SMN2SLC29A1STAT6 | |
| SCHEMBL672035 | 0.76 | SMN1; SMN2 (0.77) | TP53SMN1; SMN2SLC29A1STAT6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | claimed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | claimed |
| EP-4705313-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | The Scripps Research Institute (US) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024227159-A2 | 4'-SUBSTITUTED NUCLEOSIDES AND NUCLEOTIDES AS ANTIVIRAL AGENTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2024-10-31 | — | — | WO | disclosed |